Clovis reports a hiccup in its rociletinib trial data; regulatory approval
Clovis revealed that the US Food and Drugs Administration (FDA) had requested additional information regarding the efficacy analysis of the group’s Rociletinib drug candidate.
Posted On Nov 16 2015